AACOMmunities

Federal Funding Opportunities and Resources

Below is a selected list of timely federal funding opportunities that are relevant to the osteopathic medical education community. AACOM updates this resource frequently.  Please bookmark the page for your reference. For a comprehensive listing of federal funding opportunities, please visit Grants.gov.   

The U.S. Department of Health and Human Services (HHS) has developed a Grant Opportunities and Guidance clearinghouse across all departments where you can find information about all aspects of the grant process during the COVID-19 crisis. For example, the NIH webpage provides  information and guidance about extensions, resubmissions, and funding opportunities related to COVID-19.  Its resources are also presented here, in a daily, updated format.

 

Featured Opportunities

May 15 -28, 2021

Health Resources and Services Administration

Area Health Education Centers (AHEC) - Simulation Education Training (SET) Competitive Supplement
Application Due: June 15, 2021
The purpose of this program is to establish or enhance simulation labs that will provide realistic, clinical environments and scenarios designed to educate and train healthcare professionals serving rural, medically underserved communities. The AHEC-SET Program Competitive Supplement will develop and enhance education and training networks within communities, academic institutions, and community-based organizations through the expansion of experiential learning opportunities, including the use of simulation-based technology, as well as equipment.

Telehealth Technology-Enabled Learning Program
Application Due: June 25, 2021
This notice announces the opportunity to apply for funding under the Telehealth Technology-Enabled Learning Program (TTELP). The purpose of this program is to connect specialists at academic medical centers with primary care providers (PCPs) in rural, frontier, and underserved populations providing evidence-based training and support to help them treat patients with complex conditions in their communities.

National Institutes of Health

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
Application Due: October 14, 2021
This announcement invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations.

NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
Application Due: August 20, 2021
The NIH Director’s New Innovator Award Program supports early stage investigators of exceptional creativity who propose highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply.

Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required) 
and 
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Clinical Trial Not Allowed)
Letter of Intent Due: September 14, 2021
Application Due: October 14, 2021
This announcement invites mechanistic studies on the impact of social inequality on the brain and on the substance use trajectory. Applications investigating relevant mechanisms at the behavioral, cognitive, neurocircuitry, cellular, genetics, and epigenetics levels are encouraged.

Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) 
and 
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required)
Letter of Intent Due: September 14, 2021
Application Due: October 14, 2021
This announcement invites mechanistic studies on the impact of social inequality on the brain and on the substance use trajectory. Applications investigating relevant mechanisms at the behavioral, cognitive, neurocircuitry, cellular, genetics, and epigenetics levels are encouraged. Applications testing a fully conceptualized and hypothesis-based solid premise founded with adequate preliminary data are appropriate for this opportunity.

Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)
Letter of Intent: 30 days prior to application due date
Application Due: October 5, 2021
This initiative will support innovative research to develop, test and evaluate multi-level/multi-component strategies (including models of health care) to effectively adapt and implement comprehensive clinical care for individuals with Type 2 diabetes mellitus from populations with health disparities concordant with recommended and evidence-based guidelines.

May 1 - 14, 2021

Office of the Assistant Secretary for Health

Family-Centered Approaches to Improving Type 2 Diabetes Control and Prevention
Application Due: July 13, 2021
The Office of the Assistant Secretary for Health (OASH) and the Office of Minority Health (OMH) announce the availability of funds for Fiscal Year (FY) 2021 under the authority of 42 U.S.C. § 300u-6 (Section 1707 of the Public Health Service Act). OMH is dedicated to improving the health of racial and ethnic minority populations through the development of health policies and programs that will help eliminate health disparities. Through its demonstration grants, OMH supports the identification of effective approaches for improving health outcomes with the goal of promoting dissemination and sustainability of these approaches.

Health Resources and Services Administration

Service Area Competition
Application Due: July 12, 2021
The Health Center Program supports domestic public or private, nonprofit community-based and patient-directed organizations that provide primary health care services to the Nation’s medically underserved populations. The purpose of the SAC opportunity is to ensure continued access to comprehensive, culturally competent, high-quality primary health care services for communities and populations currently served by the Health Center Program.

National Institutes of Health

T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
Letter of Intent Due: 30 days prior to due date
Application Due: September 13, 2021
The purpose of this opportunity is to enhance the participation of individuals from diverse backgrounds, including those from groups that are nationally underrepresented in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity. The NHLBI's T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research.

Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
Application Due: June 16, 2021; AIDS Application Due: September 7, 2021
The Joint NINDS/NIMH Exploratory Neuroscience Research Grant program supports exploratory and innovative research projects, which fall within the missions of the NINDS and NIMH. Awards will provide support for the early and conceptual stages of projects. These studies often assess the feasibility of a novel avenue of investigation and involve considerable risk, but have the potential to bring about breakthroughs in the understanding of important areas of neuroscience, or to the development of novel techniques, agents, methodologies, or models, of high value to the neuroscience community.

Research Program Award (R35 Clinical Trial Optional)
Letter of Intent Due: 30 days prior to application due
Application Due: July 13, 2021
The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support, and increased freedom and flexibility, to Program Directors (PDs)/Principal Investigators (PIs), to allow them to redirect their time away from the administrative burden of writing and managing multiple grant applications and towards engaging in the lab. This RPA affords investigators at most career stages the opportunity to advance their long-term research goals, rigorously explore exciting research opportunities, and mentor students and post doctorates.

NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)
Letter of Intent Due: 30 days prior to application due
AIDS Application Due: September 7, 2021
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. These Research Education Mentoring Programs are expected to enhance the professional development of the mentees and foster career trajectories towards independent research to reduce the incidence of HIV worldwide and to decrease the burden of living with HIV. 

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) 
and 
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
Letter of Intent Due: 30 days prior to application due date
Application Due: February 15, 2022; AIDS Application Due: April 25, 2022
The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research.

Department of Defense

DOD Multiple Sclerosis Early Investigator Research Award
Pre-application Due: September 7, 2021
Application Due: October 1, 2021
The Early Investigator Research Award supports MS-focused research opportunities for individuals in the early stages of their careers, under the guidance of one or more designated Mentors. This opportunity allows for early-stage investigators to develop a research project, investigate a problem or question in MS research, and further their intellectual development as an MS researcher of the future.

DOD Multiple Sclerosis Exploration - Hypothesis Development Award
Pre-application Due: June 30, 2021
Invitation to Submit Application: August 2021
Application Due: October 1, 2021
The Exploration - Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. The studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is not required.

DOD Multiple Sclerosis Investigator-Initiated Research Award
Pre-application Due: June 30, 2021
Invitation to Submit Application: August 2021
Application Due: October 1, 2021
The IIRA supports highly rigorous, high-impact research projects that have the potential to make an important contribution to MS research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, clinical trial results, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to MS and the proposed research project.

April 19 - 21, 2021

National Institutes of Health

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
Application Due: June 12, 2021
The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience research investigators by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from diverse backgrounds, including those from groups underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of application.

NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)
Letter of Intent Due: August 3, 2021
Application Due: September 3, 2021
This award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply.

Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed)
Application Due: September 24, 2021
This opportunity encourages applications for a Resource Center as part of the Support for Research Excellence (SuRE) program to develop and sustain research excellence at U.S. higher education institutions that receive limited NIH research support and serve students from groups underrepresented in biomedical research (see NOT-OD-20-031). The Resource Center will: (1) assist SuRE-eligible institutions to build research capacity, (2) conduct outreach and training to their professional staff and faculty, and (3) collect and report data relevant to the goals of the R16 SuRE programs.

Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Letter of Intent Due: May 11, 2021
Application Due: June 11, 2021
Programs will support mentored research career development of junior faculty members, known as BIRCWH Scholars, who have recently completed clinical training or postdoctoral fellowships, and who will be engaged in interdisciplinary basic, translational, behavioral, clinical, and/or health services research relevant to the health of women.

NICHD Small Research Grant Program (R03 Clinical Trial Required)
Applications Due: June 16, 2021; AIDS Applications Due: September 7, 2021
The NICHD Small Research Grant Program (R03 Clinical Trial Required) supports clinical trials that fall within the NICHD mission. The R03 activity code supports small research projects that can be carried out in a short period of time with limited resources and may be used for different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Applications Due: June 16, 2021; AIDS Applications Due: September 7, 2021
The NICHD Small Research Grant Program (Clinical Trial Required) supports clinical trials that fall within the NICHD mission. This funding opportunity announcement is for basic science experimental studies involving humans, that meet the definition of basic research and that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind.

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Letter of Intent Due: 30 days prior to application due date
Application Due: October 8, 2021
The purpose of this Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative is to encourage research that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Letter of Intent: 30 days prior to application due date
Application Due: August 10, 2021
This opportunity supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, gene-based therapies, cell therapies, and novel emerging therapies. Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations.

NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
Letter of Intent Due: 30 days prior to application due date
Application Due: December 15, 2021
The purpose of the NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award is to support a defined pathway across career stages for outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical and behavioral sciences. This two-phase award will facilitate completion of the doctoral dissertation and transition of talented graduate students to strong neuroscience research postdoctoral positions and will provide career development opportunities relevant to their long-term career goal of becoming independent neuroscience researchers.

Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)
Letter of Intent Due: 30 days prior to application due date
Application Due: September 8, 2021
This initiative will support the identification of mechanisms behind heterogeneous responses in the population to seasonal influenza infection and/or vaccination through development and application of computational tools. Tools that can integrate molecular, genetic, cellular, patient and/or population-level data sets would specifically be targeted. The application of these tools to data being produced in existing clinical trials and cohort studies will reveal novel correlates of protection and risk for influenza as well as reveal mechanisms behind the observed outcomes.